Iron Deficiency Calculator

The Iron Deficiency Calculator evaluates iron status using key laboratory markers including serum ferritin, transferrin saturation, hemoglobin, and mean corpuscular volume (MCV). Iron deficiency is the most common nutritional deficiency worldwide, affecting an estimated 2 billion people and representing the leading cause of anemia globally. This calculator stages iron deficiency from early depletion through frank iron deficiency anemia, enabling early detection and appropriate intervention before advanced symptoms develop.

Iron deficiency progresses through three well-characterized stages. Stage 1 (Iron Depletion) represents decreased iron stores with a falling ferritin level but normal hemoglobin and red cell indices. At this stage, the body draws on stored iron to maintain hemoglobin synthesis, and patients are typically asymptomatic. Stage 2 (Iron-Deficient Erythropoiesis) occurs when stores are sufficiently depleted that iron supply to the bone marrow becomes inadequate, characterized by low ferritin, decreased transferrin saturation below 20%, and early hemoglobin decline. Stage 3 (Iron Deficiency Anemia) features overt anemia with microcytic hypochromic red blood cells (low MCV, low MCH), reflecting prolonged inadequate iron supply for hemoglobin synthesis.

Serum ferritin is the single most useful test for iron deficiency, as it directly reflects total body iron stores. A ferritin below 15 ng/mL is virtually diagnostic of iron deficiency with a specificity approaching 99%. However, ferritin is an acute-phase reactant that rises with inflammation, infection, liver disease, and malignancy. In these settings, a ferritin below 30 ng/mL or even below 100 ng/mL (in the setting of chronic kidney disease or heart failure) may still indicate iron deficiency. This dual nature of ferritin as both an iron storage marker and inflammatory marker requires careful clinical interpretation.

Transferrin saturation (TSAT) measures the percentage of circulating transferrin that is loaded with iron, reflecting current iron availability for erythropoiesis. A TSAT below 20% indicates insufficient iron delivery to the bone marrow, even if ferritin is normal. This distinction between absolute iron deficiency (low ferritin, low TSAT) and functional iron deficiency (normal or elevated ferritin, low TSAT) is clinically important, particularly in patients with chronic kidney disease, heart failure, or inflammatory conditions where both patterns are common and both respond to iron supplementation.

The clinical consequences of iron deficiency extend far beyond anemia. Iron is essential for numerous enzymatic processes including cellular energy production, DNA synthesis, and neurotransmitter metabolism. Even in the absence of anemia, iron depletion can cause fatigue, impaired exercise tolerance, cognitive dysfunction, restless legs syndrome, and pica (craving for non-food substances like ice or clay). In pregnancy, iron deficiency increases the risk of preterm delivery, low birth weight, and adverse maternal outcomes. In children, it impairs cognitive development and school performance with effects that may not be fully reversible even after iron repletion.

Treatment of iron deficiency depends on the cause, severity, and patient factors. Oral iron supplementation with ferrous sulfate, ferrous gluconate, or ferrous fumarate is first-line therapy for most patients. Intravenous iron formulations including ferric carboxymaltose, iron sucrose, and ferumoxytol are preferred when oral iron is not tolerated, not absorbed (as in celiac disease or post-gastric bypass), or when rapid repletion is needed. Identifying and addressing the underlying cause of iron loss, most commonly gastrointestinal bleeding, heavy menstruation, or inadequate dietary intake, is essential to prevent recurrence.